Rituximab in relapsing-remitting multiple sclerosis : a 72-week, open-label phase I trial

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1571135650858803712
  • NII Article ID
    10025584406
  • Data Source
    • CiNii Articles

Report a problem

Back to top